Purchase Articles
Showing 65–80 of 157 resultsSorted by latest
-
Clinical Trials in Canada: Worrying Signs Remain Despite PMPRB’s Superficial Response
Read Article -
National Strategy for Drugs for Rare Diseases should Prioritize Patients not Cost Containment
Read Article -
Health Technology Assessment Standards and Practices: How Does Canada Compare with Other Countries?
Read Article -
Clinical Trials in Canada: Worrying Signs that PMPRB Changes will Impact Research Investment
Read Article -
Essais cliniques au Canada: des signes inquiétants que l’incertitude liée aux changements du CEPMB affectera les investissements en recherche
Read Article -
Patented Medicines Expenditure in Canada 1990-2018
Read Article -
Canada’s Vaccine Development Capacity and the Federal Government’s Management of COVID-19
Read Article -
E-Mental Health Services and Unmet Needs of Canadians
Read Article -
Universal public funding for dental care in Canada: problems, policies, and politics.
Read Article -
Ensuring early access to a COVID-19 vaccine in Canada
Read Article -
Vaccines policy in Canada: International and Domestic Comparisons.
Read Article -
Career Options and Professional Integration of Internationally Trained Physicians in Canada.
Read Article -
Evidence that regulating pharmaceutical prices negatively affects R&D and access to new medicines.
Read Article -
COVID-19 Economic Costs and the Implicit Value of a Life-Year in Canada
Read Article -
Did the PMPRB censor CHPI’s Submission to its Draft Guidelines Consultation?
Read Article -
Clinical Trials in Canada Decrease: A Sign of Uncertainty Regarding Changes to the PMPRB?
Read Article